Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Muscle Invasive Bladder Cancer (NMIBC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT04412070
What this trial is testing

Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients

Who this might be right for
Bladder Cancer
Hopital Foch 20
Not applicableStudy completedNCT06126796
What this trial is testing

Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non-muscle Invasive Bladder Cancer
Mayo Clinic 107
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06829823
What this trial is testing

Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
ImmunityBio, Inc. 20
Large-scale testing (Phase 3)Looking for participantsNCT07804056
What this trial is testing

Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants With Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder Cancer

Who this might be right for
Urinary Bladder NeoplasmsNon-muscle Invasive Bladder Cancer (NMIBC)
Hamlet Pharma AB 194
Early research (Phase 1)Study completedNCT01498172
What this trial is testing

BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) Patients

Who this might be right for
Bladder Cancer
Patrice Jichlinski 23
Testing effectiveness (Phase 2)Looking for participantsNCT03945162
What this trial is testing

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Who this might be right for
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
Theralase® Technologies Inc. 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07800507
What this trial is testing

Trop2-Targeted Near-Infrared Fluorescence Imaging-Guided Precise Resection of Non-Muscle Invasive Bladder Cancer

Who this might be right for
NMIBC
Yunnan Cancer Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07777848
What this trial is testing

Evaluate the Efficacy and Safety of RAG-01 as Monotherapy and in Combination With Chemotherapy in Patients With Non-muscle Invasive Bladder Cancer (NMIBC).

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Ractigen Therapeutics. 114
Early research (Phase 1)Study completedNCT05085990
What this trial is testing

Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)

Who this might be right for
Non-muscle Invasive Bladder Cancer
Protara Therapeutics 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07189793
What this trial is testing

Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study

Who this might be right for
Urinary Bladder NeoplasmsCarcinoma, Transitional CellCarcinoma in Situ of Bladder+1 more
First Affiliated Hospital of Wenzhou Medical University 106
Testing effectiveness (Phase 2)Active Not RecruitingNCT04706598
What this trial is testing

Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment

Who this might be right for
Urinary Bladder NeoplasmsImmunotherapy
Fudan University 25
Large-scale testing (Phase 3)UnknownNCT04490993
What this trial is testing

Safety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) Patients

Who this might be right for
Non-muscle Invasive Bladder Cancer
Jiangsu Yahong Meditech Co., Ltd aka Asieris 359
Early research (Phase 1)UnknownNCT04819399
What this trial is testing

Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC

Who this might be right for
Urinary Bladder Neoplasms
Lindis Biotech GmbH 30
Testing effectiveness (Phase 2)Ended earlyNCT03167151
What this trial is testing

Pembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
University of Oxford 6
Testing effectiveness (Phase 2)Study completedNCT02015104
What this trial is testing

Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG

Who this might be right for
Bladder Cancer
National Cancer Institute (NCI) 32
Not applicableStudy completedNCT02252549
What this trial is testing

An International Randomized Study to Compare SPIES Versus WLI

Who this might be right for
Bladder Cancer
Clinical Research Office of the Endourological Society 700
Early research (Phase 1)Study completedNCT03191578
What this trial is testing

Immunological Response to Intravesical BCG Therapy of Superficial Bladder Cancer by Prior Administration of RUTI®

Who this might be right for
High-Risk Non-Muscle-Invasive Bladder Cancer
Archivel Farma S.L. 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06588179
What this trial is testing

SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt

Who this might be right for
NMIBC
Fudan University 58
Not applicableStudy completedNCT07657299
What this trial is testing

Predictive Value of E-cadherin, β-catenin and SOX4 in Recurrence and/or Progression of Non-muscle Invasive Urinary Bladder Transitional Cell Carcinoma. A Retrospective Study

Who this might be right for
Bladder CancerBladder Cancer Recurrence
Ain Shams University 30
Not applicableLooking for participantsNCT05825950
What this trial is testing

Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non-muscle-invasive Bladder Cancer
University of Texas Southwestern Medical Center 600
Next Page